Meticulous Research®, a leading market research company, has published a report titled "Europe DTC Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, Thyroid, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Forecast to 2030."
Market Growth and Projections:
The Europe direct-to-consumer (DTC) laboratory testing market is projected to reach $1.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.8% from 2023 to 2030. Key drivers include the increasing prevalence of chronic and sexually transmitted diseases, greater awareness of personal health management, the benefits of DTC testing (such as convenience, affordability, and accessibility), rising healthcare costs, growing consumer interest in ancestry and genealogy testing, and an aging population. Opportunities in telehealth adoption, emerging markets, and pharmacogenomic testing integration also contribute to market growth.
Challenges and Restraints:
The market faces challenges like genetic data privacy concerns, potential misinterpretation of test results, and the lack of professional medical counseling. Additionally, issues related to sample integrity, regulatory concerns, limited reimbursement, and a smaller test portfolio compared to conventional laboratory testing restrain growth.
For more detailed information and to download a sample report, visit: Download Sample Report
Key Players:
LetsGetChecked, Inc. (U.S.), Laboratoire CERBA (France), 23andMe Holding Co. (U.S.), Medichecks.com Ltd. (U.K.), Cerascreen Biotech LLC (U.K.), Living DNA Ltd (U.K.), SelfDiagnostics Deutschland GmbH (Germany), SYNLAB International GmbH (Germany), Natrix S.r.l. (Italy), Mainz Biomed Germany GmbH (Germany)
Market Segmentation:
The market is segmented by application, sample type, and geography.
- By Application:
- Genetic Testing: Expected to hold the largest market share in 2023, driven by interest in family health history and disease risk assessment.
- Diabetes Testing
- Routine Clinical Testing
- Thyroid Function Testing
- Sexually Transmitted Disease Testing
- Other Applications
- By Sample Type:
- Blood: Anticipated to hold the largest market share, due to the reliability of results, diverse test options, and convenience of at-home collection services.
- Saliva
- Urine
- Other Samples
- Geographic Insights:
The report covers major European regions, including Germany, the U.K., France, Spain, Italy, Switzerland, Netherlands, Belgium, Denmark, Ireland, and the Rest of Europe. The U.K. is expected to dominate the market in 2023, attributed to high consumer awareness, disposable income, and a high incidence of chronic and sexually transmitted diseases.
FOR MORE INFORMATION VISIT THE SITE NOW: https://www.meticulousresearch.com/home
Key Questions Addressed:
- What are the high-growth market segments by application, sample type, and geography?
- What are the historical and forecast market sizes for DTC laboratory testing in Europe from 2023 to 2030?
- What are the main drivers, restraints, opportunities, and challenges in the market?
- Who are the key players and market leaders?
- What is the competitive landscape?
- What are the recent market developments?
- What strategies are adopted by major players?
- What are the geographical trends and high-growth regions/countries?
PURCHASE THE FULL REPORT NOW: https://www.meticulousresearch.com/Checkout/75217288
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
0 comment